nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—liver cancer	0.79	0.875	CbGaD
Ethacrynic acid—ALB—liver cancer	0.113	0.125	CbGaD
Ethacrynic acid—GSTA2—gall bladder—liver cancer	0.00128	0.273	CbGeAlD
Ethacrynic acid—GSTA2—embryo—liver cancer	0.00081	0.173	CbGeAlD
Ethacrynic acid—GSTA2—Biological oxidations—NR1H4—liver cancer	0.000706	0.00805	CbGpPWpGaD
Ethacrynic acid—ALB—gall bladder—liver cancer	0.000703	0.15	CbGeAlD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—liver cancer	0.000697	0.00795	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTA3—liver cancer	0.000694	0.00792	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTA1—liver cancer	0.00068	0.00776	CbGpPWpGaD
Ethacrynic acid—ATP1A1—gall bladder—liver cancer	0.000677	0.145	CbGeAlD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000646	0.00737	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000641	0.00731	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000641	0.00731	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTA4—liver cancer	0.000635	0.00724	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000616	0.00703	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GGT1—liver cancer	0.000603	0.00688	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—NFE2L2—liver cancer	0.000599	0.00684	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTA1—liver cancer	0.000597	0.00681	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—NAT2—liver cancer	0.00059	0.00673	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000582	0.00664	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000582	0.00664	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GPX3—liver cancer	0.000572	0.00652	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—TGFA—liver cancer	0.000572	0.00652	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—SERPINA1—liver cancer	0.000564	0.00643	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTP1—liver cancer	0.000542	0.00618	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00054	0.00616	CbGpPWpGaD
Ethacrynic acid—ALB—Bile acid and bile salt metabolism—NR1H4—liver cancer	0.000536	0.00612	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.000515	0.00587	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTM1—liver cancer	0.000498	0.00568	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—CDH1—liver cancer	0.000475	0.00542	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—CPT1B—liver cancer	0.000474	0.0054	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—HPGDS—liver cancer	0.000472	0.00538	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000447	0.0051	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000437	0.00499	CbGpPWpGaD
Ethacrynic acid—ATP1A1—embryo—liver cancer	0.000429	0.0917	CbGeAlD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000425	0.00485	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—EPT1—liver cancer	0.000422	0.00482	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GGT1—liver cancer	0.000402	0.00459	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—CYP2E1—liver cancer	0.000384	0.00439	CbGpPWpGaD
Ethacrynic acid—GSTA2—liver—liver cancer	0.000375	0.0801	CbGeAlD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—ALDOB—liver cancer	0.000366	0.00418	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTP1—liver cancer	0.000361	0.00412	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—HMOX1—liver cancer	0.000356	0.00407	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GGT1—liver cancer	0.000353	0.00403	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000341	0.00389	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—HGF—liver cancer	0.000332	0.00379	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTM1—liver cancer	0.000332	0.00379	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000328	0.00374	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000318	0.00363	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTP1—liver cancer	0.000317	0.00362	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000313	0.00357	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—liver cancer	0.000311	0.00355	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.0003	0.00342	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.0003	0.00342	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000298	0.0034	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTM1—liver cancer	0.000291	0.00332	CbGpPWpGaD
Ethacrynic acid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—liver cancer	0.000286	0.00327	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000284	0.00324	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000284	0.00324	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—CYP1A1—liver cancer	0.000276	0.00315	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000272	0.00311	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000272	0.00311	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000258	0.00294	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000245	0.0028	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000243	0.00278	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000243	0.00278	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—GPX3—liver cancer	0.000235	0.00268	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000234	0.00267	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—UGDH—liver cancer	0.000207	0.00236	CbGpPWpGaD
Ethacrynic acid—ALB—liver—liver cancer	0.000206	0.0441	CbGeAlD
Ethacrynic acid—ATP1A1—liver—liver cancer	0.000198	0.0424	CbGeAlD
Ethacrynic acid—ALB—Platelet degranulation—SERPINA1—liver cancer	0.000198	0.00226	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—EPT1—liver cancer	0.000194	0.00222	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—liver cancer	0.000189	0.00216	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—GPX3—liver cancer	0.000186	0.00213	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TAT—liver cancer	0.000184	0.0021	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Ion channel transport—RAF1—liver cancer	0.000178	0.00203	CbGpPWpGaD
Ethacrynic acid—Dysphagia—Sorafenib—liver cancer	0.000171	0.0363	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Sorafenib—liver cancer	0.000164	0.0348	CcSEcCtD
Ethacrynic acid—Neutropenia—Sorafenib—liver cancer	0.00016	0.0339	CcSEcCtD
Ethacrynic acid—Jaundice—Sorafenib—liver cancer	0.000149	0.0315	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000149	0.0017	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—MTHFR—liver cancer	0.000148	0.00169	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.000146	0.00167	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000145	0.00165	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—TGFB1—liver cancer	0.000135	0.00154	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000131	0.0015	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—GGT1—liver cancer	0.000131	0.0015	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—F2—liver cancer	0.00013	0.00148	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Sorafenib—liver cancer	0.000128	0.0271	CcSEcCtD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000127	0.00145	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000127	0.00144	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000127	0.00144	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000126	0.00143	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CPT1B—liver cancer	0.000125	0.00143	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GLUL—liver cancer	0.000125	0.00143	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000125	0.00142	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—IGF2—liver cancer	0.000124	0.00141	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000122	0.00139	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NR1H4—liver cancer	0.000121	0.00138	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—MTHFR—liver cancer	0.00012	0.00137	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000119	0.00136	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTA3—liver cancer	0.000119	0.00135	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—liver cancer	0.000118	0.00134	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—HGF—liver cancer	0.000117	0.00133	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000114	0.0013	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000114	0.0013	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000114	0.0013	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—HGF—liver cancer	0.000111	0.00127	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HBE1—liver cancer	0.000111	0.00126	CbGpPWpGaD
Ethacrynic acid—Hyperuricaemia—Epirubicin—liver cancer	0.000109	0.023	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTA4—liver cancer	0.000109	0.00124	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SERPINE1—liver cancer	0.000108	0.00123	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000108	0.00123	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—F2—liver cancer	0.000106	0.00121	CbGpPWpGaD
Ethacrynic acid—Blood uric acid increased—Epirubicin—liver cancer	0.000103	0.0217	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTA1—liver cancer	0.000102	0.00116	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000102	0.00116	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NAT2—liver cancer	0.000101	0.00115	CbGpPWpGaD
Ethacrynic acid—Hyperuricaemia—Doxorubicin—liver cancer	0.000101	0.0213	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ALDOB—liver cancer	9.67e-05	0.0011	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—MTHFR—liver cancer	9.57e-05	0.00109	CbGpPWpGaD
Ethacrynic acid—Thrombocytopenia—Sorafenib—liver cancer	9.54e-05	0.0202	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Doxorubicin—liver cancer	9.51e-05	0.0201	CcSEcCtD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—EPT1—liver cancer	9.48e-05	0.00108	CbGpPWpGaD
Ethacrynic acid—Anorexia—Sorafenib—liver cancer	9.29e-05	0.0197	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CRABP1—liver cancer	9.23e-05	0.00105	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—PPARA—liver cancer	9.22e-05	0.00105	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—SERPINE1—liver cancer	8.8e-05	0.001	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINA1—liver cancer	8.79e-05	0.001	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Sorafenib—liver cancer	8.47e-05	0.0179	CcSEcCtD
Ethacrynic acid—Fatigue—Sorafenib—liver cancer	8.4e-05	0.0178	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—F2—liver cancer	8.4e-05	0.000959	CbGpPWpGaD
Ethacrynic acid—Pain—Sorafenib—liver cancer	8.33e-05	0.0176	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—HPGDS—liver cancer	8.07e-05	0.00092	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Sorafenib—liver cancer	7.7e-05	0.0163	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ALB—liver cancer	7.55e-05	0.000861	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—SERPINE1—liver cancer	7.54e-05	0.000861	CbGpPWpGaD
Ethacrynic acid—Hypoglycaemia—Epirubicin—liver cancer	7.51e-05	0.0159	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Epirubicin—liver cancer	7.33e-05	0.0155	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PSMD10—liver cancer	7.19e-05	0.00082	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PSMA4—liver cancer	7.19e-05	0.00082	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	7.19e-05	0.00082	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL2—liver cancer	7.12e-05	0.000813	CbGpPWpGaD
Ethacrynic acid—Asthenia—Sorafenib—liver cancer	6.99e-05	0.0148	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GOT2—liver cancer	6.99e-05	0.000798	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SERPINE1—liver cancer	6.99e-05	0.000798	CbGpPWpGaD
Ethacrynic acid—Hypoglycaemia—Doxorubicin—liver cancer	6.95e-05	0.0147	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ALB—liver cancer	6.86e-05	0.000782	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ANXA2—liver cancer	6.84e-05	0.000781	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—RAF1—liver cancer	6.83e-05	0.000779	CbGpPWpGaD
Ethacrynic acid—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	6.78e-05	0.0143	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Epirubicin—liver cancer	6.77e-05	0.0143	CcSEcCtD
Ethacrynic acid—Diarrhoea—Sorafenib—liver cancer	6.67e-05	0.0141	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CYP2E1—liver cancer	6.57e-05	0.00075	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC11A2—liver cancer	6.48e-05	0.000739	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—TNF—liver cancer	6.38e-05	0.000727	CbGpPWpGaD
Ethacrynic acid—Dysphagia—Epirubicin—liver cancer	6.33e-05	0.0134	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Doxorubicin—liver cancer	6.26e-05	0.0132	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—RAF1—liver cancer	6.2e-05	0.000707	CbGpPWpGaD
Ethacrynic acid—Vomiting—Sorafenib—liver cancer	6.2e-05	0.0131	CcSEcCtD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC40A1—liver cancer	6.18e-05	0.000705	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYCS—liver cancer	6.15e-05	0.000702	CbGpPWpGaD
Ethacrynic acid—Rash—Sorafenib—liver cancer	6.15e-05	0.013	CcSEcCtD
Ethacrynic acid—Dermatitis—Sorafenib—liver cancer	6.14e-05	0.013	CcSEcCtD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	6.11e-05	0.000697	CbGpPWpGaD
Ethacrynic acid—Headache—Sorafenib—liver cancer	6.11e-05	0.0129	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GOT1—liver cancer	6.04e-05	0.000689	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GGT1—liver cancer	6.04e-05	0.000689	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP7B—liver cancer	5.92e-05	0.000676	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ANXA2—liver cancer	5.92e-05	0.000676	CbGpPWpGaD
Ethacrynic acid—Neutropenia—Epirubicin—liver cancer	5.92e-05	0.0125	CcSEcCtD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	5.89e-05	0.000672	CbGpPWpGaD
Ethacrynic acid—Dysphagia—Doxorubicin—liver cancer	5.86e-05	0.0124	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PRKCE—liver cancer	5.79e-05	0.000661	CbGpPWpGaD
Ethacrynic acid—Nausea—Sorafenib—liver cancer	5.79e-05	0.0122	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Epirubicin—liver cancer	5.71e-05	0.0121	CcSEcCtD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	5.64e-05	0.000644	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NR1H4—liver cancer	5.6e-05	0.000639	CbGpPWpGaD
Ethacrynic acid—Jaundice—Epirubicin—liver cancer	5.51e-05	0.0116	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	5.49e-05	0.000627	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF2—liver cancer	5.49e-05	0.000626	CbGpPWpGaD
Ethacrynic acid—Neutropenia—Doxorubicin—liver cancer	5.48e-05	0.0116	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—liver cancer	5.42e-05	0.000619	CbGpPWpGaD
Ethacrynic acid—Haematuria—Epirubicin—liver cancer	5.38e-05	0.0114	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—HMOX1—liver cancer	5.35e-05	0.00061	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	5.34e-05	0.000609	CbGpPWpGaD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—liver cancer	5.29e-05	0.0112	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Epirubicin—liver cancer	5.27e-05	0.0111	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—liver cancer	5.19e-05	0.000592	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—liver cancer	5.19e-05	0.000592	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	5.18e-05	0.000591	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—liver cancer	5.15e-05	0.000587	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	5.13e-05	0.000585	CbGpPWpGaD
Ethacrynic acid—Jaundice—Doxorubicin—liver cancer	5.09e-05	0.0108	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—liver cancer	4.98e-05	0.000569	CbGpPWpGaD
Ethacrynic acid—Haematuria—Doxorubicin—liver cancer	4.98e-05	0.0105	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	4.94e-05	0.000564	CbGpPWpGaD
Ethacrynic acid—Agranulocytosis—Doxorubicin—liver cancer	4.88e-05	0.0103	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	4.78e-05	0.000545	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—TGFB1—liver cancer	4.76e-05	0.000543	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Epirubicin—liver cancer	4.73e-05	0.01	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CYP1A1—liver cancer	4.72e-05	0.000539	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—liver cancer	4.57e-05	0.000522	CbGpPWpGaD
Ethacrynic acid—Chills—Epirubicin—liver cancer	4.55e-05	0.00962	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	4.54e-05	0.000518	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINA1—liver cancer	4.53e-05	0.000517	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.5e-05	0.000514	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UGDH—liver cancer	4.49e-05	0.000512	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTHFR—liver cancer	4.4e-05	0.000502	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Doxorubicin—liver cancer	4.37e-05	0.00925	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PPARA—liver cancer	4.32e-05	0.000493	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—EPT1—liver cancer	4.22e-05	0.000482	CbGpPWpGaD
Ethacrynic acid—Chills—Doxorubicin—liver cancer	4.21e-05	0.0089	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—IL6—liver cancer	4.19e-05	0.000478	CbGpPWpGaD
Ethacrynic acid—Vision blurred—Epirubicin—liver cancer	4.16e-05	0.0088	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	4.15e-05	0.000474	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—liver cancer	4.12e-05	0.00047	CbGpPWpGaD
Ethacrynic acid—Ill-defined disorder—Epirubicin—liver cancer	4.1e-05	0.00866	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	4.02e-05	0.000459	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TAT—liver cancer	4e-05	0.000457	CbGpPWpGaD
Ethacrynic acid—Malaise—Epirubicin—liver cancer	3.98e-05	0.00842	CcSEcCtD
Ethacrynic acid—Vertigo—Epirubicin—liver cancer	3.97e-05	0.00839	CcSEcCtD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.94e-05	0.000449	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	3.86e-05	0.00044	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	3.85e-05	0.000439	CbGpPWpGaD
Ethacrynic acid—Vision blurred—Doxorubicin—liver cancer	3.85e-05	0.00814	CcSEcCtD
Ethacrynic acid—Convulsion—Epirubicin—liver cancer	3.82e-05	0.00809	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—liver cancer	3.79e-05	0.00801	CcSEcCtD
Ethacrynic acid—Anxiety—Epirubicin—liver cancer	3.74e-05	0.00792	CcSEcCtD
Ethacrynic acid—Discomfort—Epirubicin—liver cancer	3.71e-05	0.00785	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PIK3CG—liver cancer	3.7e-05	0.000422	CbGpPWpGaD
Ethacrynic acid—Malaise—Doxorubicin—liver cancer	3.68e-05	0.00779	CcSEcCtD
Ethacrynic acid—Vertigo—Doxorubicin—liver cancer	3.67e-05	0.00776	CcSEcCtD
Ethacrynic acid—Confusional state—Epirubicin—liver cancer	3.63e-05	0.00768	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PPARG—liver cancer	3.57e-05	0.000407	CbGpPWpGaD
Ethacrynic acid—Convulsion—Doxorubicin—liver cancer	3.54e-05	0.00748	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Epirubicin—liver cancer	3.53e-05	0.00746	CcSEcCtD
Ethacrynic acid—Anxiety—Doxorubicin—liver cancer	3.46e-05	0.00733	CcSEcCtD
Ethacrynic acid—Discomfort—Doxorubicin—liver cancer	3.44e-05	0.00727	CcSEcCtD
Ethacrynic acid—Anorexia—Epirubicin—liver cancer	3.43e-05	0.00726	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	3.38e-05	0.000386	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNA1—liver cancer	3.38e-05	0.000385	CbGpPWpGaD
Ethacrynic acid—Confusional state—Doxorubicin—liver cancer	3.36e-05	0.00711	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	3.35e-05	0.000382	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—liver cancer	3.33e-05	0.000379	CbGpPWpGaD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—liver cancer	3.26e-05	0.0069	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PIK3CD—liver cancer	3.25e-05	0.000371	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—liver cancer	3.21e-05	0.000366	CbGpPWpGaD
Ethacrynic acid—Anorexia—Doxorubicin—liver cancer	3.18e-05	0.00672	CcSEcCtD
Ethacrynic acid—Decreased appetite—Epirubicin—liver cancer	3.13e-05	0.00662	CcSEcCtD
Ethacrynic acid—Fatigue—Epirubicin—liver cancer	3.11e-05	0.00657	CcSEcCtD
Ethacrynic acid—Pain—Epirubicin—liver cancer	3.08e-05	0.00652	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	3.02e-05	0.000345	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKCE—liver cancer	2.99e-05	0.000341	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Epirubicin—liver cancer	2.97e-05	0.00628	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	2.95e-05	0.000336	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.95e-05	0.000336	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Doxorubicin—liver cancer	2.9e-05	0.00613	CcSEcCtD
Ethacrynic acid—Fatigue—Doxorubicin—liver cancer	2.87e-05	0.00608	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	2.87e-05	0.000327	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	2.86e-05	0.000326	CbGpPWpGaD
Ethacrynic acid—Pain—Doxorubicin—liver cancer	2.85e-05	0.00603	CcSEcCtD
Ethacrynic acid—Body temperature increased—Epirubicin—liver cancer	2.85e-05	0.00602	CcSEcCtD
Ethacrynic acid—ALB—Hemostasis—ABL1—liver cancer	2.84e-05	0.000324	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CB—liver cancer	2.83e-05	0.000323	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF2—liver cancer	2.83e-05	0.000323	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Doxorubicin—liver cancer	2.75e-05	0.00581	CcSEcCtD
Ethacrynic acid—ALB—Metabolism—GLUL—liver cancer	2.72e-05	0.00031	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CPT1B—liver cancer	2.72e-05	0.00031	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	2.71e-05	0.000309	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HGF—liver cancer	2.67e-05	0.000305	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CSF2—liver cancer	2.64e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Doxorubicin—liver cancer	2.63e-05	0.00557	CcSEcCtD
Ethacrynic acid—ALB—Metabolism—NR1H4—liver cancer	2.62e-05	0.000299	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	2.59e-05	0.000296	CbGpPWpGaD
Ethacrynic acid—Asthenia—Epirubicin—liver cancer	2.58e-05	0.00547	CcSEcCtD
Ethacrynic acid—ALB—Metabolism—GSTA3—liver cancer	2.58e-05	0.000294	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.48e-05	0.000283	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Epirubicin—liver cancer	2.46e-05	0.00521	CcSEcCtD
Ethacrynic acid—Asthenia—Doxorubicin—liver cancer	2.39e-05	0.00506	CcSEcCtD
Ethacrynic acid—ALB—Metabolism—GSTA4—liver cancer	2.36e-05	0.000269	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.31e-05	0.000263	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.3e-05	0.000263	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA2—liver cancer	2.3e-05	0.000262	CbGpPWpGaD
Ethacrynic acid—Vomiting—Epirubicin—liver cancer	2.29e-05	0.00484	CcSEcCtD
Ethacrynic acid—Diarrhoea—Doxorubicin—liver cancer	2.28e-05	0.00482	CcSEcCtD
Ethacrynic acid—Rash—Epirubicin—liver cancer	2.27e-05	0.0048	CcSEcCtD
Ethacrynic acid—Dermatitis—Epirubicin—liver cancer	2.27e-05	0.0048	CcSEcCtD
Ethacrynic acid—Headache—Epirubicin—liver cancer	2.26e-05	0.00477	CcSEcCtD
Ethacrynic acid—ALB—Metabolism—GSTA1—liver cancer	2.22e-05	0.000253	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAT2—liver cancer	2.19e-05	0.00025	CbGpPWpGaD
Ethacrynic acid—Nausea—Epirubicin—liver cancer	2.14e-05	0.00453	CcSEcCtD
Ethacrynic acid—ALB—Hemostasis—MAPK14—liver cancer	2.14e-05	0.000244	CbGpPWpGaD
Ethacrynic acid—Vomiting—Doxorubicin—liver cancer	2.12e-05	0.00448	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.11e-05	0.000241	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.11e-05	0.000241	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDOB—liver cancer	2.1e-05	0.00024	CbGpPWpGaD
Ethacrynic acid—Rash—Doxorubicin—liver cancer	2.1e-05	0.00444	CcSEcCtD
Ethacrynic acid—Dermatitis—Doxorubicin—liver cancer	2.1e-05	0.00444	CcSEcCtD
Ethacrynic acid—Headache—Doxorubicin—liver cancer	2.09e-05	0.00442	CcSEcCtD
Ethacrynic acid—ALB—Hemostasis—F2—liver cancer	2.07e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CRABP1—liver cancer	2.01e-05	0.000229	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.01e-05	0.000229	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CG—liver cancer	1.98e-05	0.000226	CbGpPWpGaD
Ethacrynic acid—Nausea—Doxorubicin—liver cancer	1.98e-05	0.00419	CcSEcCtD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.81e-05	0.000206	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.8e-05	0.000205	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPGDS—liver cancer	1.75e-05	0.0002	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CD—liver cancer	1.74e-05	0.000199	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.74e-05	0.000199	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—liver cancer	1.73e-05	0.000197	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINE1—liver cancer	1.72e-05	0.000197	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.59e-05	0.000181	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSMD10—liver cancer	1.56e-05	0.000178	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSMA4—liver cancer	1.56e-05	0.000178	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RAF1—liver cancer	1.56e-05	0.000178	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GOT2—liver cancer	1.52e-05	0.000173	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CB—liver cancer	1.52e-05	0.000173	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.47e-05	0.000168	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2E1—liver cancer	1.43e-05	0.000163	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKT1—liver cancer	1.41e-05	0.000161	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—liver cancer	1.4e-05	0.000159	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.38e-05	0.000158	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.35e-05	0.000154	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYCS—liver cancer	1.34e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GOT1—liver cancer	1.31e-05	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GGT1—liver cancer	1.31e-05	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—liver cancer	1.19e-05	0.000135	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—liver cancer	1.18e-05	0.000134	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMOX1—liver cancer	1.16e-05	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB1—liver cancer	1.09e-05	0.000124	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—liver cancer	1.08e-05	0.000124	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A1—liver cancer	1.03e-05	0.000117	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—liver cancer	1.01e-05	0.000115	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTHFR—liver cancer	9.57e-06	0.000109	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARA—liver cancer	9.39e-06	0.000107	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—liver cancer	9.27e-06	0.000106	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—liver cancer	8.96e-06	0.000102	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HRAS—liver cancer	8.57e-06	9.78e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.44e-06	9.63e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CG—liver cancer	8.04e-06	9.18e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARG—liver cancer	7.76e-06	8.86e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT1—liver cancer	7.57e-06	8.64e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CD—liver cancer	7.07e-06	8.07e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CB—liver cancer	6.16e-06	7.03e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—liver cancer	3.76e-06	4.29e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKT1—liver cancer	3.07e-06	3.5e-05	CbGpPWpGaD
